Horizon Therapeutics Public Total Assets 2009-2021 | HZNP

Horizon Therapeutics Public total assets from 2009 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Horizon Therapeutics Public total assets for the quarter ending March 31, 2021 were $7.847B, a 81.86% increase year-over-year.
  • Horizon Therapeutics Public total assets for 2020 were $6.073B, a 36.89% increase from 2019.
  • Horizon Therapeutics Public total assets for 2019 were $4.436B, a 12.53% increase from 2018.
  • Horizon Therapeutics Public total assets for 2018 were $3.942B, a 6.2% decline from 2017.
Horizon Therapeutics Public Annual Total Assets
(Millions of US $)
2020 $6,073
2019 $4,436
2018 $3,942
2017 $4,202
2016 $4,292
2015 $3,059
2014 $1,114
2013 $253
2012 $194
2011 $101
2010 $162
2009 $8
2008 $15
2007 $0
Horizon Therapeutics Public Quarterly Total Assets
(Millions of US $)
2021-03-31 $7,847
2020-12-31 $6,073
2020-09-30 $5,767
2020-06-30 $4,538
2020-03-31 $4,315
2019-12-31 $4,436
2019-09-30 $3,721
2019-06-30 $3,708
2019-03-31 $3,936
2018-12-31 $3,942
2018-09-30 $4,019
2018-06-30 $3,990
2018-03-31 $4,003
2017-12-31 $4,202
2017-09-30 $4,169
2017-06-30 $4,170
2017-03-31 $4,375
2016-12-31 $4,292
2016-09-30 $3,350
2016-06-30 $3,227
2016-03-31 $3,205
2015-12-31 $3,059
2015-09-30 $2,999
2015-06-30 $2,943
2015-03-31 $1,527
2014-12-31 $1,114
2014-09-30 $1,125
2014-06-30 $328
2014-03-31 $299
2013-12-31 $253
2013-09-30 $158
2013-06-30 $159
2013-03-31 $170
2012-12-31 $194
2012-09-30 $212
2012-06-30 $149
2012-03-31 $170
2011-12-31 $101
2011-09-30 $189
2011-06-30 $172
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2009-12-31 $8
2008-12-31 $15
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $19.456B $2.200B
Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.115B 15.55
Bristol Myers Squibb (BMY) United States $144.085B 9.99
CSL (CSLLY) Australia $96.112B 0.00
Gilead Sciences (GILD) United States $84.594B 9.01
Moderna (MRNA) United States $61.305B 122.14
Vertex Pharmaceuticals (VRTX) United States $55.056B 22.67
Illumina (ILMN) United States $54.435B 78.49
Regeneron Pharmaceuticals (REGN) United States $54.331B 15.47
BioNTech SE (BNTX) Germany $44.954B 32.60
Biogen (BIIB) United States $41.255B 9.44
Alexion Pharmaceuticals (ALXN) United States $38.013B 14.44
BeiGene (BGNE) Cayman Islands $28.670B 0.00
Seagen (SGEN) United States $26.272B 45.38
Genmab (GMAB) Denmark $23.828B 27.95
Genmab (GNMSF) Denmark $22.666B 5.21
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.732B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.806B 45.69
Incyte (INCY) United States $18.115B 35.81
CureVac (CVAC) Germany $17.562B 0.00
Exact Sciences (EXAS) United States $16.488B 0.00
Bio-Techne Corp (TECH) United States $15.902B 83.62
Alnylam Pharmaceuticals (ALNY) United States $15.676B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.815B 126.00
Zai Lab (ZLAB) China $13.782B 0.00
ARGENX SE-ADR (ARGX) Netherlands $13.248B 0.00
Guardant Health (GH) United States $11.521B 0.00
QIAGEN (QGEN) Netherlands $10.551B 18.74
Novavax (NVAX) United States $9.471B 0.00
Repligen (RGEN) United States $9.422B 84.95
AbCellera Biologics (ABCL) $8.323B 0.00
Exelixis (EXEL) United States $7.885B 125.80
Mirati Therapeutics (MRTX) United States $7.880B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.641B 0.00
Ascendis Pharma (ASND) Denmark $7.362B 0.00
Acceleron Pharma (XLRN) United States $7.355B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.180B 0.00
Fate Therapeutics (FATE) United States $6.798B 0.00
Denali Therapeutics (DNLI) United States $6.201B 222.48
Halozyme Therapeutics (HALO) United States $6.049B 33.19
Sarepta Therapeutics (SRPT) United States $5.895B 0.00
Blueprint Medicines (BPMC) United States $5.347B 16.28
Vir Biotechnology (VIR) United States $5.086B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $4.950B 17.93
Galapagos (GLPG) Belgium $4.857B 0.00
Adaptive Biotechnologies (ADPT) United States $4.618B 0.00
I-Mab (IMAB) China $4.494B 0.00
NeoGenomics (NEO) United States $4.467B 757.60
Twist Bioscience (TWST) United States $4.453B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $4.443B 0.00
Intellia Therapeutics (NTLA) United States $4.362B 0.00
Beam Therapeutics (BEAM) United States $4.185B 0.00
Certara (CERT) United States $4.138B 0.00
Legend Biotech (LEGN) United States $4.037B 0.00
Apellis Pharmaceuticals (APLS) United States $3.750B 0.00
Arena Pharmaceuticals (ARNA) United States $3.716B 0.00
Alkermes (ALKS) Ireland $3.601B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.497B 0.00
SpringWorks Therapeutics (SWTX) United States $3.431B 0.00
Emergent Biosolutions (EBS) United States $3.140B 6.25
Arvinas (ARVN) United States $3.087B 0.00
Intra-Cellular Therapies (ITCI) United States $3.048B 0.00
Reata Pharmaceuticals (RETA) United States $2.955B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.883B 40.74
Insmed (INSM) United States $2.738B 0.00
Berkeley Lights (BLI) United States $2.638B 0.00
MorphoSys AG (MOR) Germany $2.625B 0.00
Amicus Therapeutics (FOLD) United States $2.453B 0.00
Global Blood Therapeutics (GBT) United States $2.279B 0.00
ALX Oncology Holdings (ALXO) United States $2.200B 0.00
Vericel (VCEL) United States $2.188B 590.00
Kymera Therapeutics (KYMR) United States $2.163B 0.00
Editas Medicine (EDIT) United States $2.151B 0.00
NGM Biopharmaceuticals (NGM) United States $2.150B 0.00
Ligand Pharmaceuticals (LGND) United States $2.087B 34.92
Arcus Biosciences (RCUS) United States $2.070B 0.00
Bluebird Bio (BLUE) United States $2.013B 0.00
Revance Therapeutics (RVNC) United States $1.998B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.978B 0.00
Myriad Genetics (MYGN) United States $1.957B 0.00
Instil Bio (TIL) United States $1.943B 0.00
Seres Therapeutics (MCRB) United States $1.922B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.913B 0.00
PHARMA MAR SA (PHMMF) Spain $1.894B 0.00
Myovant Sciences (MYOV) United Kingdom $1.891B 0.00
Sorrento Therapeutics (SRNE) United States $1.886B 0.00
Heska (HSKA) United States $1.885B 821.82
Morphic Holding (MORF) United States $1.784B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.764B 0.00
Seer (SEER) $1.751B 0.00
Cytokinetics (CYTK) United States $1.745B 0.00
Amarin (AMRN) Ireland $1.711B 0.00
Ocugen (OCGN) United States $1.707B 0.00
Genetron Holdings (GTH) China $1.668B 0.00
Atea Pharmaceuticals (AVIR) United States $1.633B 0.00
BioAtla (BCAB) United States $1.616B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.544B 0.00
C4 Therapeutics (CCCC) United States $1.513B 0.00
Sangamo Therapeutics (SGMO) United States $1.506B 0.00
PureTech Health (PRTC) United States $1.497B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.494B 0.00
Curis (CRIS) United States $1.489B 0.00
REGENXBIO (RGNX) United States $1.480B 0.00
UniQure (QURE) Netherlands $1.471B 0.00
Precigen (PGEN) United States $1.406B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.364B 0.00
Alector (ALEC) United States $1.339B 0.00
Bionano Genomics (BNGO) United States $1.321B 0.00
Inovio Pharmaceuticals (INO) United States $1.319B 0.00
Castle Biosciences (CSTL) United States $1.306B 0.00
Protagonist Therapeutics (PTGX) United States $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.286B 0.00
Zymeworks (ZYME) Canada $1.273B 0.00
Northwest Biotherapeutics (NWBO) United States $1.243B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.238B 0.00
Avid Bioservices (CDMO) United States $1.192B 0.00
Repare Therapeutics (RPTX) Canada $1.191B 0.00
Travere Therapeutics (TVTX) United States $1.172B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Shattuck Labs (STTK) United States $1.163B 0.00
Nurix Therapeutics (NRIX) United States $1.155B 0.00
Codexis (CDXS) United States $1.147B 0.00
Keros Therapeutics (KROS) United States $1.131B 0.00
Pliant Therapeutics (PLRX) United States $1.118B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.077B 0.00
Coherus BioSciences (CHRS) United States $1.049B 0.00
MiMedx (MDXG) United States $1.016B 0.00
Celldex Therapeutics (CLDX) United States $1.014B 0.00
Mersana Therapeutics (MRSN) United States $1.009B 0.00
MannKind (MNKD) United States $1.001B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.998B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.989B 31.23
Scholar Rock Holding (SRRK) United States $0.984B 0.00
Prothena (PRTA) Ireland $0.965B 0.00
Sutro Biopharma (STRO) United States $0.937B 0.00
Affimed (AFMD) Germany $0.898B 0.00
Avidity Biosciences (RNA) United States $0.876B 0.00
Epizyme (EPZM) United States $0.872B 0.00
G1 THERAPEUTICS (GTHX) United States $0.868B 0.00
Mesoblast (MESO) Australia $0.867B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.865B 0.00
Merus (MRUS) Netherlands $0.855B 0.00
Pharming Group (PHAR) Netherlands $0.834B 0.00
Dynavax Technologies (DVAX) United States $0.831B 0.00
Nkarta (NKTX) United States $0.826B 0.00
Cel-Sci (CVM) United States $0.807B 0.00
Pharming Group (PHGUF) Netherlands $0.782B 20.83
Adaptimmune Therapeutics (ADAP) United Kingdom $0.752B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.729B 0.00
VBI Vaccines (VBIV) United States $0.727B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.714B 0.00
Bolt Biotherapeutics (BOLT) United States $0.697B 0.00
AnaptysBio (ANAB) United States $0.696B 0.00
Cellectis S.A (CLLS) France $0.695B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.692B 0.00
Agenus (AGEN) United States $0.674B 0.00
DBV Technologies S.A (DBVT) France $0.664B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.663B 0.00
Prometheus Biosciences (RXDX) United States $0.663B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.662B 0.00
Cara Therapeutics (CARA) United States $0.657B 57.09
Sinovac Biotech (SVA) China $0.642B 6.47
IDEAYA Biosciences (IDYA) United States $0.636B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.632B 0.00
Kadmon Holdings (KDMN) United States $0.616B 0.00
Inhibrx (INBX) United States $0.609B 0.00
Anika Therapeutics (ANIK) United States $0.607B 0.00
Clovis Oncology (CLVS) United States $0.597B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.589B 0.00
MeiraGTx Holdings (MGTX) United States $0.583B 0.00
ALBIREO PHARMA (ALBO) United States $0.570B 0.00
Starpharma Holdings (SPHRY) Australia $0.546B 0.00
Adagene (ADAG) China $0.546B 0.00
Inventiva S.A (IVA) France $0.541B 0.00
CytomX Therapeutics (CTMX) United States $0.514B 0.00
XBiotech (XBIT) United States $0.510B 0.00
Precision BioSciences (DTIL) United States $0.510B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.484B 0.00
Verastem (VSTM) United States $0.481B 0.00
RAPT THERAPTICS (RAPT) United States $0.478B 0.00
ChromaDex (CDXC) United States $0.470B 0.00
Compugen (CGEN) Israel $0.470B 0.00
Forte Biosciences (FBRX) United States $0.458B 0.00
AC Immune SA (ACIU) Switzerland $0.456B 0.00
Neoleukin Therapeutics (NLTX) United States $0.452B 0.00
Athenex (ATNX) United States $0.441B 0.00
Cue Biopharma (CUE) United States $0.441B 0.00
Clene (CLNN) United States $0.441B 0.00
Geron (GERN) United States $0.440B 0.00
HOOKIPA Pharma (HOOK) United States $0.434B 0.00
Angion Biomedica (ANGN) United States $0.429B 0.00
Adicet Bio (ACET) United States $0.419B 0.00
ANI Pharmaceuticals (ANIP) United States $0.415B 11.45
Gritstone Oncology (GRTS) United States $0.415B 0.00
SESEN BIO, INC (SESN) United States $0.411B 0.00
Amryt Pharma (AMYT) United Kingdom $0.409B 0.00
BeyondSpring (BYSI) United States $0.394B 0.00
Puma Biotechnology (PBYI) United States $0.392B 0.00
Seelos Therapeutics (SEEL) United States $0.382B 0.00
UROGEN PHARMA (URGN) United States $0.379B 0.00
Spero Therapeutics (SPRO) United States $0.379B 0.00
Codiak BioSciences (CDAK) United States $0.372B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.367B 0.00
Adverum Biotechnologies (ADVM) United States $0.362B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.362B 0.00
AquaBounty Technologies (AQB) United States $0.362B 0.00
Fortress Biotech (FBIO) United States $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.354B 0.00
Kala Pharmaceuticals (KALA) United States $0.354B 0.00
Frequency Therapeutics (FREQ) United States $0.346B 0.00
Oncobiologics (OTLK) United States $0.344B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.343B 0.00
Athersys (ATHX) United States $0.342B 0.00
Fulcrum Therapeutics (FULC) United States $0.340B 0.00
Selecta Biosciences (SELB) United States $0.340B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.339B 0.00
XOMA (XOMA) United States $0.338B 158.00
Opthea (OPT) Australia $0.337B 0.00
Theratechnologies (THTX) Canada $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.324B 0.00
Innate Pharma S.A (IPHA) France $0.321B 0.00
SQZ Biotechnologies (SQZ) United States $0.321B 0.00
IBio (IBIO) United States $0.320B 0.00
Cardiff Oncology (CRDF) United States $0.319B 0.00
BioDelivery Sciences (BDSI) United States $0.317B 12.88
ProQR Therapeutics (PRQR) Netherlands $0.317B 0.00
WAVE Life Sciences (WVE) Singapore $0.305B 0.00
Cogent Biosciences (COGT) United States $0.305B 0.00
CorMedix Inc (CRMD) United States $0.299B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Talis Biomedical (TLIS) United States $0.283B 0.00
Bellus Health (BLU) Canada $0.273B 0.00
Kaleido Biosciences (KLDO) $0.270B 0.00
Arbutus Biopharma (ABUS) United States $0.262B 0.00
Kamada (KMDA) Israel $0.261B 17.76
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.254B 0.00
Trevena (TRVN) United States $0.247B 0.00
Chiasma (CHMA) United States $0.240B 0.00
OVID THERAPEUTC (OVID) United States $0.237B 0.00
Prima BioMed (IMMP) Australia $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.229B 0.00
Cerecor (CERC) United States $0.225B 0.00
NextCure (NXTC) United States $0.221B 0.00
ADMA Biologics Inc (ADMA) United States $0.203B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.193B 0.00
Eton Pharmaceuticals (ETON) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.191B 0.00
VTv Therapeutics (VTVT) United States $0.186B 0.00
Checkpoint Therapeutics (CKPT) United States $0.181B 0.00
TELA Bio (TELA) United States $0.174B 0.00
Nicox SA (NICXF) France $0.170B 0.00
Voyager Therapeutics (VYGR) United States $0.169B 4.34
VolitionRX (VNRX) United States $0.167B 0.00
Aptinyx (APTX) United States $0.165B 0.00
Applied Genetic Technologies (AGTC) United States $0.161B 0.00
ObsEva SA (OBSV) Switzerland $0.157B 0.00
Antibe Therapeutics (ATBPF) Canada $0.156B 0.00
Biofrontera AG (BFRA) Germany $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 0.00
Erytech Pharma SA (ERYP) France $0.151B 0.00
INmune Bio (INMB) United States $0.150B 0.00
Exicure (XCUR) United States $0.148B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Liquidia Technologies (LQDA) United States $0.142B 0.00
Clearside Biomedical (CLSD) United States $0.141B 0.00
X4 Pharmaceuticals (XFOR) United States $0.140B 0.00
Abeona Therapeutics (ABEO) United States $0.140B 0.00
Enzo Biochem (ENZ) United States $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.135B 0.00
Protalix BioTherapeutics (PLX) Israel $0.135B 0.00
Synlogic (SYBX) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
ABVC BioPharma (ABVC) United States $0.129B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.129B 0.00
Evofem Biosciences (EVFM) United States $0.129B 0.00
DiaMedica Therapeutics (DMAC) United States $0.127B 0.00
Liminal BioSciences (LMNL) Canada $0.127B 0.00
Pluristem Therapeutics (PSTI) Israel $0.122B 0.00
Eyenovia (EYEN) United States $0.120B 0.00
Galena Biopharma (SLS) United States $0.119B 0.00
Palatin Technologies (PTN) United States $0.114B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.113B 0.00
Beyond Air (XAIR) United States $0.105B 0.00
Dyadic (DYAI) United States $0.105B 0.00
Orgenesis (ORGS) United States $0.103B 209.50
Cyclerion Therapeutics (CYCN) United States $0.101B 0.00
Longeveron (LGVN) United States $0.100B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.100B 0.00
Armata Pharmaceuticals (ARMP) United States $0.100B 0.00
Aptevo Therapeutics (APVO) United States $0.097B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
TRACON Pharmaceuticals (TCON) United States $0.096B 0.00
Leap Therapeutics (LPTX) United States $0.095B 0.00
Aytu BioPharma (AYTU) United States $0.095B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
Novogen (KZIA) Australia $0.095B 0.00
Vascular Biogenics (VBLT) Israel $0.093B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Lumos Pharma (LUMO) United States $0.083B 0.00
Edesa Biotech (EDSA) Canada $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.079B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.079B 0.00
Cocrystal Pharma (COCP) United States $0.079B 0.00
Adocia (ADOCY) France $0.077B 0.00
AIkido Pharma (AIKI) United States $0.076B 0.00
Celyad SA (CYAD) Belgium $0.075B 0.00
Entera Bio (ENTX) Israel $0.072B 0.00
ARIDIS PHARMACT (ARDS) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.070B 0.00
Cleveland BioLabs (CBLI) United States $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.068B 0.00
Purple Biotech (PPBT) Israel $0.066B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
ATyr Pharma (LIFE) United States $0.062B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.060B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
ZIVO Bioscience (ZIVO) United States $0.056B 0.00
AEterna Zentaris (AEZS) United States $0.055B 0.00
BioCardia (BCDA) United States $0.055B 0.00
Advaxis (ADXS) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
Windtree Therapeutics (WINT) United States $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.049B 0.00
Pulmatrix (PULM) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.048B 0.00
Cyclo Therapeutics (CYTH) United States $0.046B 0.00
Enveric Biosciences (ENVB) United States $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Invo BioScience (INVO) United States $0.041B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.041B 0.00
Acorda Therapeutics (ACOR) United States $0.040B 0.97
Timber Pharmaceuticals (TMBR) United States $0.040B 0.00
Yumanity Therapeutics (YMTX) United States $0.039B 0.00
Soligenix (SNGX) United States $0.038B 0.00
GeoVax Labs (GOVX) United States $0.033B 0.00
Vyant Bio (VYNT) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.027B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Vallon Pharmaceuticals (VLON) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Benitec Biopharma (BNTC) United States $0.021B 0.00
Palisade Bio (PALI) United States $0.015B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
Viridian Therapeutics (VRDN) United States $0.000B 0.00